Sample Type,Primary Tumor Site,Primary Tumor Location,Age at Diagnosis,Stage at Diagnosis,Gender,Molecular Subtype,MSIsensor Score,mCRC Type,Chemo Exposure of sequenced specimen,Metastasectomy,Time to metastasis (months),Time from Met Dx to Sequencing,Tumor Grade,Liver: First Site of Metastasis,Lymph Nodes: First Site of Metastasis,Lung: First Site of Metastasis,Pelvis: First Site of Metastasis,Brain: First Site of Metastasis,Bone: First Site of Metastasis,"Peritoneum, omentum, abdomen: First Site of Metastasis",Gynecological: First Site of Metastasis,Other: First Site of Metastasis,Level R1,Level 2B,Level 3A,Level 3B,Highest Level of Actionability,Number of actionable alterations (OncoKb) ,BRAF classes for patients with BRAF mutations,Genomic Pathway Goups,Samples for MSS Right/Left mCRC anslysis,Samples for MSS Right/Left analysis,Samples for MSS Right/Left early stage analysis,Samples for MSS mCRC analysis,Hypermutated,Mutation Rate (mut/mb),Fraction of Genome Altered,Ratio of Indel to Substitutions,Average Sample Alele Frequency
Metastasis,Cecum,Right,47,III,1,MSS,0.42,mCRC Metastasis,1,1,15.3,13.06666667,poorly-diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.797101449,0.260652335,0.142857143,0.342462045
Metastasis,Sigmoid Colon,Left,44,IV,0,MSS,0.49,mCRC Metastasis,1,1,0.0,14.06666667,mod_diff,1,0,0,0,0,0,0,1,1,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.971014493,0.082753951,0.375,0.418086827
Metastasis,Sigmoid Colon,Left,63,IV,0,MSS,1.51,mCRC Metastasis,0,0,0.0,30.9,mod_diff,1,1,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,alpelisib(PIK3CA p.E542K);alpelisib(PIK3CA p.M1043I),LEVEL_3B,2,Not_Provided,PI3k_RAS,1,1,0,1,0,5.0,0.309264813,0.2,0.72651626
Primary,Rectum,Left,31,III,0,MSI,12.1,mCRC Primary,1,0,12.8,5.233333333,Not_Provided,1,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,0,0,0,0,1,40.83333333,0.157672112,0.065217391,0.520305481
Metastasis,Sigmoid Colon,Left,49,IV,1,MSS,0.15,mCRC Metastasis,0,1,0.0,49.8,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.164829993,0.125,0.347018319
Primary,Rectosigmoid,Left,63,IV,1,MSS,1.23,mCRC Primary,0,0,0.0,4.166666667,Not_Provided,1,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12V);Cetuximab,Panitumumab(KRAS p.D33E)",Not_Provided,0.0,alpelisib(PIK3CA p.E545G),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,9.420289855,0.151490407,0.444444444,0.328084177
Metastasis,Rectosigmoid,Left,37,IV,1,MSS,2.16,mCRC Metastasis,1,1,0.0,42.16666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.320348332,0.25,0.520895816
Primary,Rectum,Left,58,IV,1,MSS,1.77,mCRC Primary,0,0,0.0,1.9,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,7.971014493,0.229362899,0.0,0.506188945
Metastasis,Not_Provided,Not_Provided,70,IV,1,MSS,2.82,mCRC Metastasis,0,0,0.0,21.6,Not_Provided,1,0,1,0,1,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,0,0,1,0,6.52173913,0.365778277,0.0,0.506284398
Metastasis,Sigmoid Colon,Left,33,IV,0,MSS,1.41,mCRC Metastasis,1,1,0.0,29.23333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.219047648,0.25,0.493618145
Metastasis,Descending Colon,Left,64,IV,0,MSS,1.22,mCRC Metastasis,1,1,0.0,96.6,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.297724786,0.25,0.480651377
Metastasis,Rectum,Left,45,IV,1,MSS,0.0,mCRC Metastasis,1,0,0.0,17.3,mod_diff,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,4.347826087,0.074292442,0.0,0.289497272
Metastasis,Cecum,Right,60,III,1,MSS,0.65,mCRC Metastasis,1,1,0.0,19.13333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.353574012,0.75,0.414562148
Metastasis,Rectosigmoid,Left,43,IV,0,MSS,0.32,mCRC Metastasis,1,1,0.0,39.23333333,mod_diff,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,2.173913043,0.001235358,0.0,0.337772143
Metastasis,Sigmoid Colon,Left,31,IV,0,MSS,1.1,mCRC Metastasis,0,1,0.0,2.333333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.358974592,0.666666667,0.381114813
Primary,Cecum,Right,47,IV,1,POLE,1.26,mCRC Primary,0,1,0.0,2.7,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.K117N)",Crizotinib(MET p.X1087_splice);Everolimus(TSC1 p.E218*);Olaparib(BRCA2 p.K3032*),0.0,"alpelisib(PIK3CA p.R38H);Capmatinib,Cabozatinib(MET p.X1087_splice)",LEVEL_2B,5,No_class,PI3k_RAS,0,0,0,0,1,173.9130435,0.0016792,0.0041841,0.47400587
Metastasis,Splenic Flexure,Left,69,IV,0,MSS,1.91,mCRC Metastasis,1,0,0.0,13.23333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12S)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.072463768,0.344135131,0.0,0.354797597
Primary,Rectum,Left,65,IV,0,MSS,1.23,mCRC Primary,0,0,0.0,10.83333333,Not_Provided,1,1,0,0,0,0,0,0,1,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,"AZD4547,Dovitinib(FGFR1 Amplification)",LEVEL_3B,1,Not_Provided,RAS,1,1,0,1,0,5.0,0.285135592,0.0,0.326671841
Metastasis,Colon,Not_Provided,48,IV,0,MSS,0.48,mCRC Metastasis,0,0,0.0,2.366666667,Not_Provided,1,0,0,1,0,0,0,1,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,0,0,1,0,7.246376812,0.326091167,0.25,0.564004718
Primary,Ascending Colon,Right,51,IV,0,MSS,0.16,mCRC Primary,0,1,0.0,8.866666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.5,0.128228108,0.125,0.70467675
Primary,Cecum,Right,35,IV,1,MSS,0.34,mCRC Primary,0,0,0.0,2.1,poorly-diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.921568627,0.046432024,0.0,0.389512818
Metastasis,Cecum,Right,59,III,1,MSS,0.19,mCRC Metastasis,1,1,19.86666667,43.56666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.614379085,0.220825187,1.0,0.534761961
Metastasis,Sigmoid Colon,Left,76,IV,1,MSS,3.28,mCRC Metastasis,1,0,0.0,54.96666667,mod diff,1,1,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,0,0,0,0,0,7.246376812,0.27461407,0.111111111,0.447627115
Primary,Cecum,Right,55,IV,0,MSS,0.85,mCRC Primary,1,1,0.0,64.26666667,mod_diff,1,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.18584816,0.0,0.459380333
Primary,Splenic Flexure,Left,48,IV,0,MSS,0.17,mCRC Primary,0,1,0.0,2.0,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.072463768,0.001691871,0.166666667,0.331623718
Metastasis,Rectum,Left,58,IV,1,MSS,0.0,mCRC Metastasis,1,1,0.0,63.36666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12S)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.060857899,0.125,0.42818562
Metastasis,Sigmoid Colon,Left,24,IV,0,MSS,0.89,mCRC Metastasis,1,1,0.0,97.16666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Crizotinib(MET Amplification),0.0,Not_Provided,LEVEL_2B,1,Not_Provided,RAS,1,1,0,1,0,5.0,0.391219207,0.0,0.458453123
Primary,Rectum,Left,48,IV,1,MSS,0.0,mCRC Primary,0,0,0.0,1.4,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,0,0,0,0,4.347826087,0.019066967,0.2,0.427616167
Primary,Hepatic Flexure,Right,58,IV,0,MSS,0.69,mCRC Primary,0,0,0.0,5.466666667,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13C)",Not_Provided,0.0,Neratinib(ERBB2 p.V777L),LEVEL_3B,1,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.200369378,0.4,0.587301861
Metastasis,Descending Colon,Left,64,IV,1,MSS,0.52,mCRC Metastasis,1,1,0.0,30.53333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,alpelisib(PIK3CA p.H1047R),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,6.52173913,0.113084018,0.285714286,0.344609026
Primary,Cecum,Right,65,IV,1,MSS,0.0,mCRC Primary,0,0,0.0,17.53333333,poorly-diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,1.666666667,0.00246764,0.0,0.374245849
Primary,Cecum,Right,68,IV,0,MSS,0.07,mCRC Primary,0,1,0.0,2.166666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.167759802,0.25,0.50126577
Metastasis,Rectum,Left,59,IV,0,MSS,0.91,mCRC Metastasis,1,1,120.0,114.1333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.314049156,0.5,0.640072713
Primary,Sigmoid Colon,Left,48,IV,1,MSS,0.62,mCRC Primary,1,1,0.0,8.633333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.Q61H)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.177394454,0.333333333,0.491423835
Metastasis,Hepatic Flexure,Right,62,IV,0,MSS,0.18,mCRC Metastasis,1,1,0.0,66.2,mod_diff,1,0,0,0,0,0,0,1,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,7.5,0.214113351,0.125,0.465994779
Primary,Cecum,Right,43,IV,0,MSS,1.55,mCRC Primary,0,0,0.0,10.43333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,alpelisib(PIK3CA p.M1043L),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.797101449,0.375573934,0.142857143,0.462446271
Primary,Rectum,Left,74,IV,1,MSS,0.0,mCRC Primary,0,1,0.0,1.766666667,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.026019945,0.111111111,0.407780757
Metastasis,Rectosigmoid,Left,53,III,1,MSS,1.06,mCRC Metastasis,1,1,15.06666667,0.766666667,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.A146T)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.271718149,0.166666667,0.450539498
Primary,Rectum,Left,33,IV,0,MSS,2.07,mCRC Primary,0,0,0.0,5.133333333,mod_diff,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.304352447,0.333333333,0.406601526
Metastasis,Sigmoid Colon,Left,44,III,0,MSS,0.59,mCRC Metastasis,1,1,14.5,6.766666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,0.0,alpelisib(PIK3CA p.E542K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.072463768,0.088483677,0.166666667,0.589513438
Metastasis,Cecum,Right,69,IV,1,MSS,0.75,mCRC Metastasis,1,0,0.0,3.166666667,mod_diff,1,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.321855241,0.0,0.60251285
Primary,Rectum,Left,51,IV,0,MSS,0.08,mCRC Primary,0,1,0.0,45.9,mod_diff,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,alpelisib(PIK3CA p.E365K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,10.14492754,0.108813103,0.076923077,0.196648486
Metastasis,Rectosigmoid,Left,44,IV,0,MSS,0.07,mCRC Metastasis,1,0,0.0,7.8,Not_Provided,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.043821707,0.4,0.410408703
Primary,Descending Colon,Left,53,IV,1,MSS,0.23,mCRC Primary,0,0,0.0,12.3,Not_Provided,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.A146V)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.091183749,0.0,0.294128883
Primary,Rectum,Left,71,IV,0,MSS,0.15,mCRC Primary,0,0,0.0,3.466666667,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.K117N)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.173913043,0.010175606,0.0,0.33965474
Metastasis,Rectum,Left,62,III,0,MSS,0.42,mCRC Metastasis,1,0,7.133333333,3.233333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(NRAS p.Q61K)",Not_Provided,0.0,"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61K)",LEVEL_3B,1,Not_Provided,RAS,1,1,0,1,0,7.971014493,0.179468163,0.222222222,0.38358076
Primary,Cecum,Right,73,IV,1,MSS,0.15,mCRC Primary,1,0,0.0,10.06666667,mod_diff,1,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,AG-221(IDH2 p.R172K),LEVEL_3B,1,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.059510491,0.2,0.410234701
Metastasis,Descending Colon,Left,52,IV,0,MSS,0.0,mCRC Metastasis,0,0,0.0,1.8,Not_Provided,1,0,1,0,0,0,0,0,1,"Cetuximab,Panitumumab(KRAS p.A146T)",Not_Provided,0.0,alpelisib(PIK3CA p.E542K);AG-221(IDH2 p.R172K),LEVEL_3B,2,Not_Provided,PI3k_RAS,1,1,0,1,0,8.695652174,0.038707564,0.090909091,0.642836457
Metastasis,Sigmoid Colon,Left,54,IV,0,MSS,0.26,mCRC Metastasis,1,0,0.0,17.83333333,mod_diff,1,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.338085264,0.0,0.46215542
Primary,Ascending Colon,Right,43,IV,0,MSS,0.09,mCRC Primary,0,0,0.0,14.93333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.072463768,0.128353329,0.166666667,0.359139258
Primary,Transverse Colon,Right,45,IV,0,MSS,0.21,mCRC Primary,0,0,0.0,4.4,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,alpelisib(PIK3CA p.H1047R),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.072463768,0.062638752,0.166666667,0.374913327
Primary,Rectum,Left,59,IV,1,MSS,2.27,mCRC Primary,1,1,0.0,37.5,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12S)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,10.0,0.303751176,0.0,0.471650102
Primary,Ascending Colon,Right,64,IV,0,MSS,0.34,mCRC Primary,1,0,0.0,11.3,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.173913043,0.026204914,0.0,0.488731817
Primary,Rectosigmoid,Left,53,IV,0,MSS,1.6,mCRC Primary,1,0,0.0,17.16666667,Not_Provided,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.175188034,0.4,0.339364724
Metastasis,Rectum,Left,62,IV,1,MSS,0.47,mCRC Metastasis,0,1,0.0,2.9,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.075279652,0.0,0.361025685
Primary,Descending Colon,Left,65,IV,0,MSS,1.03,mCRC Primary,0,0,0.0,14.33333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)","Erlotinib,Gefitinib,Afatinib(EGFR p.L861Q)",0.0,alpelisib(PIK3CA p.E542K),LEVEL_2B,2,Not_Provided,PI3k_RAS,1,1,0,1,0,12.5,0.010551969,0.153846154,0.485986714
Metastasis,Cecum,Right,58,II,1,MSS,0.08,mCRC Metastasis,1,1,21.4,26.1,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.097040014,0.0,0.431797141
Primary,Sigmoid Colon,Left,49,III,0,MSS,0.46,mCRC Primary,0,1,12.9,17.13333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,alpelisib(PIK3CA p.E542K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,6.52173913,0.145294954,0.125,0.483400642
Primary,Hepatic Flexure,Right,48,IV,1,MSS,0.5,mCRC Primary,0,0,0.0,3.933333333,poorly-diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,7.246376812,0.117062454,0.25,0.476883361
Primary,Rectosigmoid,Left,56,II,0,MSS,0.73,mCRC Primary,0,0,11.33333333,31.46666667,mod_diff,1,1,1,1,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.17836555,0.333333333,0.344660489
Metastasis,Rectum,Left,40,IV,0,MSS,0.61,mCRC Metastasis,1,1,0.0,28.16666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.157750376,1.0,0.416479124
Primary,Rectum,Left,36,IV,1,MSS,1.03,mCRC Primary,0,0,0.0,11.03333333,Not_Provided,1,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.A146V)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.372110311,0.4,0.592072315
Primary,Cecum,Right,60,IV,1,MSS,0.0,mCRC Primary,0,0,0.0,15.03333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.5,0.119293614,0.0,0.327498558
Metastasis,Sigmoid Colon,Left,47,I,0,MSS,1.29,mCRC Metastasis,0,1,8.333333333,43.86666667,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.833333333,0.259778394,0.0,0.466909465
Metastasis,Sigmoid Colon,Left,43,IV,1,MSS,2.72,mCRC Metastasis,1,0,0.0,40.56666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.Q61H)",Not_Provided,0.0,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.753677829,0.166666667,0.514509019
